LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anxiety Disorders
- Patients
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: randomized, double-blind, placebo-controlled, crossoverMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: randomized, double-blind, placebo-controlled, crossoverPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 25 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03153579
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Peter Gasser, MD Private Practice